Venmax Drugs and Pharmaceuticals informs about un-audited financial results

06 Dec 2022 Evaluate

Pursuant to Reg.30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Venmax Drugs and Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on 28th October, 2021 had approved the Un Audited financial results of the Company for the Quarter & Half Yearly ended 30th September, 2021 and Limited Review Report of the Auditors thereon.

The above information is a part of company’s filings submitted to BSE.

Venmax Drugs&Pharma Share Price

27.90 -1.31 (-4.48%)
30-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.20
Dr. Reddys Lab 1183.00
Cipla 1549.65
Lupin 2094.65
Zydus Lifesciences 887.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...